Remove 2024 Remove Cardiothoracic Remove Heart Valves
article thumbnail

Columbia Cardiology Launches New Mitral & Tricuspid Center

DAIC

Kodali, MD, pictured here, is one of the members of its leadership team, and director of the Structural Heart and Valve Center at CUIMC/NewYork-Presbyterian Hospital. According to Kodali, the Center’s wealth of expertise and experience will help drive these advances.

Tricuspid 111
article thumbnail

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. 3 Based on internal test report D00997823, Avalus Ultra Full Valve Stiffness Design Verification Report.

article thumbnail

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. 3 Based on internal test report D00997823, Avalus Ultra Full Valve Stiffness Design Verification Report.

article thumbnail

Columbia Cardiology Launches New Mitral and Tricuspid Center

DAIC

Kodali, MD, pictured here, is one of the members of its leadership team, and director of the Structural Heart and Valve Center at CUIMC/NewYork-Presbyterian Hospital. According to Kodali, the Center’s wealth of expertise and experience will help drive these advances.

article thumbnail

Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device

DAIC

Henry Ford Health's Center for Structural Heart Disease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heart failure patient on February 13, 2024 at Henry Ford Hospital in Detroit.

article thumbnail

New Late-breaking Data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-effectiveness Benefits of TAVR Platform

DAIC

milla1cf Tue, 03/12/2024 - 16:48 March 12, 2024 — Medtronic plc , a global leader in healthcare technology, today announced two late-breaking data presentations on four-year outcomes from the Evolut Low Risk Trial. At Medtronic, we continue to emphasize that valve design matters. mmHg TAVR; 11.8

TAVR 52
article thumbnail

The Texas Heart Institute Collaborates on Multi-institutional DOD Grant to Develop Novel Left Ventricular Assist Device

DAIC

He is an expert in prosthetic heart valves and cardiovascular biomechanics, biomaterials and devices. Cavallaro’s group to develop computer algorithms to monitor the electrical conduction of the heart and modify LVAD pump operation as needed. Dasi , PhD, Rozelle Vanda Wesley Professor in the Wallace H.